FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893390437> ?p ?o ?g. }

• W2893390437 endingPage "S5" @default.
• W2893390437 startingPage "S4" @default.
• W2893390437 abstract "Despite the proven benefit of oral anticoagulation (OAC) in reducing the risk of stroke among atrial fibrillation (AF) patients, there is lingering concern that persistence with these life-saving medications is suboptimal in routine clinical practice. From a prospective registry, we sought to examine: (i) the one-year persistence rates to warfarin and non-vitamin K oral anticoagulants (NOAC) and (ii) factors associated with OAC persistence. We enrolled 2,498 AF patients from 132 community-based sites in Canada (November 2013 to March 2016) in a prospective registry. Use of OAC at one year was ascertained by telephone follow-up. Multivariable logistic regression was performed to examine for factors associated with continued OAC use (vs. non-use) at one-year. Among patients who remained treated with OAC at one-year, a multivariable logistic regression was performed to examine for factors associated with use of the same OAC agent vs. being switched to another OAC agent. Among the 2,010 patients treated with OAC at baseline, one-year data on OAC use were obtained for 1,387 (69%) patients. In this cohort, 124 patients (8.9%) were no longer treated with OAC at one-year. The rates of OAC discontinuation of warfarin- and NOAC-treated patients were 5.1% and 10.5%, respectively (P<0.05). The distribution of OAC use at one-year, stratified by baseline OAC use, was shown in the figure. On multivariable regression analysis, use of NOAC and concomitant use of antiplatelet agents were associated with increased likelihood of OAC discontinuation at one-year (odds ratio (OR) 2.22, 95% CI 1.35-3.70 and OR 2.50, 95% CI 1.54-4.00). Among patients who remained treated with OAC at one-year, the odds of staying on the same OAC agent were higher for patients treated with factor Xa inhibitors when compared to those treated with warfarin at baseline (OR 1.64, 95% CI 1.05-2.54 (rivaroxaban vs. warfarin) and OR 5.26, 95% CI 2.22-12.5 (apixaban vs. warfarin)). Similar results were obtained when our analysis was restricted to patients treated with the same OAC for >90 days prior to their baseline visit. In this contemporary Canadian AF registry, the one-year persistence rates of OAC were high irrespective of the type of agent prescribed. Among patients who experienced a change in their OAC use, warfarin-treated patients were more likely to switch to NOACs instead of stopping OAC. NOAC-treated patients were more likely to discontinue use of OAC altogether rather than being switched to warfarin." @default.
• W2893390437 created "2018-10-05" @default.
• W2893390437 creator A5004831482 @default.
• W2893390437 creator A5008947092 @default.
• W2893390437 creator A5018121224 @default.
• W2893390437 creator A5022185581 @default.
• W2893390437 creator A5024418476 @default.
• W2893390437 creator A5033359636 @default.
• W2893390437 creator A5034189278 @default.
• W2893390437 creator A5050507154 @default.
• W2893390437 creator A5064509338 @default.
• W2893390437 creator A5084263263 @default.
• W2893390437 creator A5085095228 @default.
• W2893390437 creator A5085796494 @default.
• W2893390437 date "2018-10-01" @default.
• W2893390437 modified "2023-09-27" @default.
• W2893390437 title "PERSISTENCE OF ORAL ANTICOAGULANT USE AMONG CANADIAN ATRIAL FIBRILLATION PATIENTS: ONE-YEAR RESULTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY" @default.
• W2893390437 doi "https://doi.org/10.1016/j.cjca.2018.07.379" @default.
• W2893390437 hasPublicationYear "2018" @default.
• W2893390437 type Work @default.
• W2893390437 sameAs 2893390437 @default.
• W2893390437 citedByCount "0" @default.
• W2893390437 crossrefType "journal-article" @default.
• W2893390437 hasAuthorship W2893390437A5004831482 @default.
• W2893390437 hasAuthorship W2893390437A5008947092 @default.
• W2893390437 hasAuthorship W2893390437A5018121224 @default.
• W2893390437 hasAuthorship W2893390437A5022185581 @default.
• W2893390437 hasAuthorship W2893390437A5024418476 @default.
• W2893390437 hasAuthorship W2893390437A5033359636 @default.
• W2893390437 hasAuthorship W2893390437A5034189278 @default.
• W2893390437 hasAuthorship W2893390437A5050507154 @default.
• W2893390437 hasAuthorship W2893390437A5064509338 @default.
• W2893390437 hasAuthorship W2893390437A5084263263 @default.
• W2893390437 hasAuthorship W2893390437A5085095228 @default.
• W2893390437 hasAuthorship W2893390437A5085796494 @default.
• W2893390437 hasBestOaLocation W28933904371 @default.
• W2893390437 hasConcept C126322002 @default.
• W2893390437 hasConcept C127413603 @default.
• W2893390437 hasConcept C151956035 @default.
• W2893390437 hasConcept C187320778 @default.
• W2893390437 hasConcept C188816634 @default.
• W2893390437 hasConcept C2776301958 @default.
• W2893390437 hasConcept C2778715236 @default.
• W2893390437 hasConcept C2779161974 @default.
• W2893390437 hasConcept C2779384505 @default.
• W2893390437 hasConcept C2781009140 @default.
• W2893390437 hasConcept C71924100 @default.
• W2893390437 hasConcept C72563966 @default.
• W2893390437 hasConceptScore W2893390437C126322002 @default.
• W2893390437 hasConceptScore W2893390437C127413603 @default.
• W2893390437 hasConceptScore W2893390437C151956035 @default.
• W2893390437 hasConceptScore W2893390437C187320778 @default.
• W2893390437 hasConceptScore W2893390437C188816634 @default.
• W2893390437 hasConceptScore W2893390437C2776301958 @default.
• W2893390437 hasConceptScore W2893390437C2778715236 @default.
• W2893390437 hasConceptScore W2893390437C2779161974 @default.
• W2893390437 hasConceptScore W2893390437C2779384505 @default.
• W2893390437 hasConceptScore W2893390437C2781009140 @default.
• W2893390437 hasConceptScore W2893390437C71924100 @default.
• W2893390437 hasConceptScore W2893390437C72563966 @default.
• W2893390437 hasIssue "10" @default.
• W2893390437 hasLocation W28933904371 @default.
• W2893390437 hasOpenAccess W2893390437 @default.
• W2893390437 hasPrimaryLocation W28933904371 @default.
• W2893390437 hasRelatedWork W1531487536 @default.
• W2893390437 hasRelatedWork W2007116565 @default.
• W2893390437 hasRelatedWork W2010333783 @default.
• W2893390437 hasRelatedWork W2050156493 @default.
• W2893390437 hasRelatedWork W2106143461 @default.
• W2893390437 hasRelatedWork W2388584347 @default.
• W2893390437 hasRelatedWork W2624418005 @default.
• W2893390437 hasRelatedWork W2883509736 @default.
• W2893390437 hasRelatedWork W3022287464 @default.
• W2893390437 hasRelatedWork W3133753204 @default.
• W2893390437 hasVolume "34" @default.
• W2893390437 isParatext "false" @default.
• W2893390437 isRetracted "false" @default.
• W2893390437 magId "2893390437" @default.
• W2893390437 workType "article" @default.